Implant Sciences Receives Orders for QS-B220 Bench-Top Explosives and
Newsletter Subscription


Thursday, April 17, 2014


Implant Sciences Receives Orders for QS-B220 Bench-Top Explosives and Narcotics Trace Detectors

  • New Product Launch Showing Early Success in China
Wilmington, MA - Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security markets, today announced it has received its first orders for the recently introduced Quantum Sniffer(TM) QS-B220 bench-top explosives and narcotics trace detector from China.

With over 800 units installed in numerous locations, the Company's QS-H150 portable explosives trace detector has gained significant market traction in China for a wide range of deployments across the country. Because of its increased sensitivity for explosives and its new narcotics detection capability, the QS-B220 extends the reach of Implant Sciences' product line, providing additional opportunity for new potential customers in security, customs, and corrections facilities.

Related Research on ASDReports.com:
Airport Passenger Screening Systems Market 2013-2023

"The QS-B220 has received a very positive response from customers in China. We, and our Chinese distributors, believe the new Quantum Sniffer bench-top has the strong potential to meet and exceed the kind of sales levels we've seen in China for the QS-H150 portable unit. We anticipate that these units are just the beginning for the QS-B220," stated Glenn D. Bolduc, President and CEO of Implant Sciences.

Source : Implant Sciences Corp.

Published on ASDNews: Oct 13, 2011

 

Prisons and Correctional Facilities 2014 Conference

Jun 9 - 11, 2014 - Washington, United States

Register More info


US Export Controls with REFORM CHANGES Seminar

Sep 22 - 25, 2014 - Austin, United States

Register More info


Night Vision Systems 2014 Summit

Jul 21 - 23, 2014 - Washington, United States

Register More info


© 2004-2014 • ASDNews • be the first to know • contact usterms & conditionsprivacy policyadvertisingfaqs